On May 18th, 2015 CVBF organised in collaboration with the University Hospital Center “Mother Teresa” (UHCT), an Open Meeting in Tirana with the aim to foster the clinical research in Albania and raise the attention on the importance of the European Networks to create synergies to spread excellence and attract European funding. The meeting, promoted in the framework of the Eu-funded project DEEP (DEferiprone Evaluation in Paediatrics) was accredited by the Albanian National Centre of Continuing Education, QKEV and provided 101 participants with 5 CME credits for Continuing education for healthcare professionals. […]
On June 2nd, 2015, the city of Lushnja (Albania) hosted the first edition of the Scientific Conference on Thalassaemia at the City History Museum, with the participation of international prominent personalities in the field of clinical research, such as Prof. Adriana Ceci (Scientific Director of Consorzio per Valutazioni Biologiche e Farmacologiche and President of Gianni Benzi Pharmacological Research Foundation), Prof. Gaspare Adorno and Prof Francesco Brancati from the University of Rome “Tor Vergata”, Prof. Natale Capodicasa (President of the Association of donors in Tirana) and Prof. Aldo Brancati (Dean of the Faculty of Medicine, Università Nostra Signora del Buon Consiglio – UCNSBC of Tirana). The Scientific Conference has been officially opened by the Chief Executive Officer of CVBF Albania, Donato Bonifazi, the Mayor, Fatos Tushe and the General Secretary of the “Associazione TALASSEMICI”, Mura Zenelaj. […]
CVBF is glad to announce the recent opening, on May 13th, 2015, of the branch office in Tirana acting as a Contract Research Organisation (CRO) to conduct GCP (Good Clinical Practice) Clinical Trials supporting pharmaceutical companies willing to invest in research in this country. The decision to undertake this strong partnership with Albania, puts its bases on the solid and durable relationship established over the years with the University Hospital Centre “Mother Teresa” of Tirana, the undertaken GCP educational path, the local willingness to adequate their research level to the European requirements and the recent update of the Albanian Law (31st July 2014) on Drugs and Pharmaceutical services including six articles specifically addressing issues on clinical trials. Actually CVBF, is conducting as a Contract Research Organisation (CRO) two clinical studies in Europe involving Albania (DEEP and GAPP) and in this regard, on the basis of this solid expertise of the Consortium, the branch office of Tirana could represent a strategic hub to conduct GCP clinical trials. The Albanian staff will works close to the Italian personnel to comply with ICH-GCP and European. The staff members of the Albanian branch include Dr. M. Kreka, CVBF Medical Director, Dr. J. Millo, CVBF Clinical Research Associate, and Dr. Lena M., CVBF Project Assistant.